This company listing is no longer active
Global Blood Therapeutics Gestion
Gestion contrôle des critères 3/4
Informations clés
Ted Love
Directeur général
US$8.2m
Rémunération totale
Pourcentage du salaire du PDG | 8.7% |
Durée du mandat du directeur général | 8.3yrs |
Propriété du PDG | 1.4% |
Durée moyenne d'occupation des postes de direction | 6.5yrs |
Durée moyenne du mandat des membres du conseil d'administration | 5.8yrs |
Mises à jour récentes de la gestion
Recent updates
Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -US$322m |
Mar 31 2022 | n/a | n/a | -US$310m |
Dec 31 2021 | US$8m | US$716k | -US$303m |
Sep 30 2021 | n/a | n/a | -US$277m |
Jun 30 2021 | n/a | n/a | -US$266m |
Mar 31 2021 | n/a | n/a | -US$249m |
Dec 31 2020 | US$18m | US$661k | -US$248m |
Sep 30 2020 | n/a | n/a | -US$282m |
Jun 30 2020 | n/a | n/a | -US$286m |
Mar 31 2020 | n/a | n/a | -US$291m |
Dec 31 2019 | US$10m | US$597k | -US$267m |
Sep 30 2019 | n/a | n/a | -US$220m |
Jun 30 2019 | n/a | n/a | -US$199m |
Mar 31 2019 | n/a | n/a | -US$182m |
Dec 31 2018 | US$10m | US$569k | -US$174m |
Sep 30 2018 | n/a | n/a | -US$166m |
Jun 30 2018 | n/a | n/a | -US$152m |
Mar 31 2018 | n/a | n/a | -US$135m |
Dec 31 2017 | US$8m | US$520k | -US$117m |
Sep 30 2017 | n/a | n/a | -US$103m |
Jun 30 2017 | n/a | n/a | -US$95m |
Mar 31 2017 | n/a | n/a | -US$89m |
Dec 31 2016 | US$1m | US$479k | -US$82m |
Sep 30 2016 | n/a | n/a | -US$71m |
Jun 30 2016 | n/a | n/a | -US$65m |
Mar 31 2016 | n/a | n/a | -US$58m |
Dec 31 2015 | US$2m | US$438k | -US$51m |
Rémunération vs marché: Ted's total compensation ($USD8.19M) is above average for companies of similar size in the German market ($USD2.68M).
Rémunération et revenus: Ted's compensation has been consistent with company performance over the past year.
PDG
Ted Love (63 yo)
8.3yrs
Titularisation
US$8,193,309
Compensation
Dr. Ted W. Love, M.D., serves as Independent Director at Royalty Pharma plc since July 30, 2020. He serves as Director of Seagen Inc. (formerly known as Seattle Genetics, Inc.). since August 2020. He serve...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 8.3yrs | US$8.19m | 1.37% € 64.1m | |
CFO & Principal Accounting Officer | 6.5yrs | US$2.76m | 0.040% € 1.9m | |
Chief Business & Strategy Officer | 7.5yrs | US$2.73m | 0.37% € 17.5m | |
Chief Commercial Officer | 4.6yrs | US$2.75m | 0.084% € 3.9m | |
Executive VP and Head of Research & Development | 1.4yrs | US$2.98m | 0.0089% € 415.3k | |
Founder & Advisor | 11.8yrs | pas de données | pas de données | |
Founder & Advisor | 11.8yrs | pas de données | pas de données | |
Founder & Advisor | 11.8yrs | pas de données | pas de données | |
Executive Vice President of Operations | 2.5yrs | pas de données | 0.062% € 2.9m | |
Senior Director of Corporate Communications & Investor Relations | no data | pas de données | pas de données | |
Chief Legal Officer & Secretary | 6yrs | US$5.93m | 0.064% € 3.0m | |
Senior VP & Head of Corporate Communications | 3.8yrs | pas de données | pas de données |
6.5yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Gestion expérimentée: G5B's management team is seasoned and experienced (6.5 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 9.1yrs | US$8.19m | 1.37% € 64.1m | |
Lead Independent Director | 7.5yrs | US$348.28k | 0.056% € 2.6m | |
Independent Director | 4.8yrs | US$320.78k | 0.017% € 794.5k | |
Independent Director | 2.4yrs | US$313.28k | 0.013% € 627.7k | |
Independent Director | 6.7yrs | US$318.28k | 0.039% € 1.8m | |
Independent Director | 7.1yrs | US$310.78k | 0.013% € 632.8k | |
Independent Director | 6.8yrs | US$333.28k | 0.0098% € 461.3k | |
Independent Director | 3.8yrs | US$316.36k | 0.0080% € 373.6k | |
Advisor & Director Emeritus | less than a year | US$308.28k | 0.058% € 2.7m | |
Independent Director | 1.6yrs | US$735.61k | 0.0049% € 229.7k |
5.8yrs
Durée moyenne de l'emploi
66yo
Âge moyen
Conseil d'administration expérimenté: G5B's board of directors are considered experienced (5.8 years average tenure).